NantHealth, Inc (NH)

Etorro trading 970x250
NantHealth, Inc (NH) Logo

About NantHealth, Inc

NantHealth, Inc., together with its subsidiaries, operates as a healthcare IT company in the United States and internationally. It offers Eviti, a software-as-a-service (SaaS) based clinical decision support solution that centralizes clinical content and treatment cost data from Medicare reimbursements and treatment toxicity data; Eviti Connect, which utilizes the platform to offer pre-authorization automation that helps payers and providers navigate the complexities of cancer care; and Eviti Advisor product that allows physicians to access the Eviti platform’s comprehensive library of evidence-based treatment standards and protocols to inform treatment decisions. The company also provides NaviNet, a suite of SaaS-based solution enabling payers and providers to streamline communication and consolidate information; NaviNet Open, a payer-provider collaboration platform for communication between health plans and providers; NaviNet AllPayer that provides eligibility, benefit, and claim status information to provider offices for commercial and government plans and CMS for Medicare beneficiaries through the NaviNet portal; and OpenNMS is an open-source network monitoring solution for enterprise-grade networks. In addition, it offers GPS Cancer, a comprehensive molecular profile that integrates whole genome/exome (DNA) sequencing of tumor and normal germline samples and whole transcriptome (RNA) sequencing; Omics Core, an in-vitro diagnostic built on a custom-targeted whole exome sequencing platform; and Quadris, a data solution that includes multi-data analysis, reporting, and professional service. The company was formerly known as Nant Health, LLC and changed its name to NantHealth, Inc. in June 2016. The company was incorporated in 2010 and is headquartered in Culver City, California. NantHealth, Inc. is as a subsidiary of NantWorks, LLC. Address: 9920 Jefferson Boulevard, Culver City, CA, United States, 90232

NantHealth, Inc News and around…

Latest news about NantHealth, Inc (NH) common stock and company :

NantHealth Teams Up with Care Continuity for Patient Navigation and Care Coordination Across the Healthcare Continuum
18 Oct, 2021 FinancialContent

NantHealth, Inc. (NASDAQ-GS: NH), a leading provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced an agreement with Care Continuity Inc., a leader in network integrity and care navigation across the care continuum. The agreement was formed to improve the management of care logistics for complex, high risk and chronic diseases. The care pathways enabled by this collaboration will support clinicians, patients, and their families across health networks, and help to ensure patients receive equal, high-quality access to treatment. The initial focus is the extension of cancer pathways through Eviti® Connect, then adding other high risk and chronic care pathways through NantHealth’s NaviNet® payer/provider collaboration platform.

NantHealth’s Chief Medical Officer to Educate on Advancing Equity in Cancer Care at the Oncology Clinical Pathways Congress 2021
29 Sep, 2021 FinancialContent

NantHealth, Inc. (NASDAQ: NH), a provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced that Dr. Tiffany Avery, Chief Medical Officer, was selected to present a continuing education session at the Oncology Clinical Pathways Congress 2021. Dr. Avery’s session, titled Utilizing Pathways to Advance Equity in Cancer Care, will take place virtually on Friday, October 1, 2021, and cover how clinical pathways can promote equity in oncology by recognizing the existence of bias in cancer care.

A NantHealth, Inc. (NASDAQ:NH) insider increased their holdings last year
27 Sep, 2021 Yahoo! Finance

Looking at NantHealth, Inc.'s ( NASDAQ:NH ) insider transactions over the last year, we can see that insiders were net...

NantHealth and Intraprise Health Announce Collaboration to Help Providers Meet HIPAA Compliance Requirements and Protect Patient Data with HIPAA One Solution
08 Sep, 2021 FinancialContent

NantHealth, Inc. (NASDAQ: NH), a provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced a collaboration with Intraprise Health, the provider of HIPAA One Security and Privacy Compliance software. HIPAA One’s Security Risk Assessment software will now be available to the growing network of healthcare provider offices utilizing NantHealth’s NaviNet® solution, offering a comprehensive solution to manage HIPAA compliance requirements.

Return on Capital Employed Overview: NantHealth
02 Sep, 2021 FinancialContent

According to Benzinga Pro data, during Q2, NantHealth (NASDAQ:NH) posted sales of $16.09 million. Earnings were up 8.35%, but ...

NantHealth, Inc. Common Stock (NH) Q2 2021 Earnings Call Transcript
06 Aug, 2021 FinancialContent

NH earnings call for the period ending June 30, 2021.

NantHealth, Inc. (NH) Reports Q2 Loss, Lags Revenue Estimates
05 Aug, 2021 Yahoo! Finance

NantHealth, Inc. (NH) delivered earnings and revenue surprises of 20.00% and -5.35%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

NantHealth Reports 2021 Second Quarter Financial Results
05 Aug, 2021 FinancialContent

NantHealth, Inc. (NASDAQ-GS: NH), a provider of enterprise solutions that help businesses transform complex data into actionable insights, today reported financial results for its second quarter ended June 30, 2021.

The VIX Gets Crushed Fueling The Stock Markets Advance On August 3
04 Aug, 2021 FinancialContent

The S&P 500 rebounded today, rising 80 bps to a new closing high. The index started lower but managed to find some buying after Europe closed around 11:30.

NantHealth Appoints Dr. Tiffany Avery as Chief Medical Officer
03 Aug, 2021 FinancialContent

NantHealth, Inc. (NASDAQ: NH), a provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced the appointment of Tiffany Avery, MD, MPH, as Chief Medical Officer. In her new position, Dr. Avery will be responsible for providing clinical strategic direction and guiding the development and deployment of NantHealth’s Eviti decision support platform and other innovative products and services.

NantHealth to Report 2021 Second-Quarter Financial Results and Host Conference Call on Thursday, August 5
02 Aug, 2021 FinancialContent

NantHealth, Inc. (NASDAQ-GS: NH), a provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced that it will report financial results for its 2021 second quarter on Thursday, August 5, 2021, after market close. NantHealth management will host a conference call that same day at 1:30 p.m. PT (4:30 p.m. ET) to review the company’s performance.

Analysts Estimate NantHealth, Inc. (NH) to Report a Decline in Earnings: What to Look Out for
29 Jul, 2021 Yahoo! Finance

NantHealth, Inc. (NH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

NantHealth's(NASDAQ:NH) Share Price Is Down 79% Over The Past Five Years.
27 Jul, 2021 Yahoo! Finance

Long term investing works well, but it doesn't always work for each individual stock. We don't wish catastrophic...

Where Do Hedge Funds Stand On NantHealth, Inc. (NH)?
14 Jun, 2021 Yahoo! Finance

In this article we are going to use hedge fund sentiment as a tool and determine whether NantHealth, Inc. (NASDAQ:NH) is a good investment right now. We like to analyze hedge fund sentiment before conducting days of in-depth research. We do so because hedge funds and other elite investors have numerous Ivy League graduates, expert […]

NantHealth, Inc. Common Stock (NH) Q1 2021 Earnings Call Transcript
07 May, 2021 FinancialContent

NH earnings call for the period ending March 31, 2021.

NantHealth Reports 2021 First Quarter Financial Results
06 May, 2021 FinancialContent

NantHealth, Inc. (NASDAQ-GS: NH), a provider of enterprise solutions that help businesses transform complex data into actionable insights, today reported financial results for its first quarter ended March 31, 2021.

NantHealth, Inc. to Host Earnings Call
06 May, 2021 Yahoo! Finance

NEW YORK, NY / ACCESSWIRE / May 6, 2021 / NantHealth, Inc. (NASDAQ:NH) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 6, 2021 at 4:30 PM Eastern Time.

A Preview Of NantHealth's Earnings
05 May, 2021 FinancialContent

NantHealth (NASDAQ:NH) unveils its next round of earnings this Thursday, May 06. Get prepared with Benzinga's ultimate preview for ...

NantHealth Launches Eviti Connect For Autoimmune Diseases
05 May, 2021 FinancialContent

NantHealth, Inc. (NASDAQ: NH), a provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced the launch of Eviti Connect for autoimmune diseases, aimed at helping payers and providers realize the quickest path to approving cost-effective, quality care for patients. Eviti Connect is a go-to resource in the oncology space and has helped providers find evidence-based care for more than 345,000 cancer patients while saving payers hundreds of millions of dollars. NantHealth is now expanding the use of its expertise, data, and resources to aid providers and payers in navigating the costs and treatment options of autoimmune diseases.

NantHealth to Report 2021 First-Quarter Financial Results and Host Conference Call on Thursday, May 6
04 May, 2021 FinancialContent

NantHealth, Inc. (NASDAQ-GS: NH), a provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced that it will report financial results for its 2021 first quarter on Thursday, May 6, 2021, after market close. NantHealth management will host a conference call that same day at 1:30 p.m. PT (4:30 p.m. ET) to review the company’s performance.

Interesting NH Put And Call Options For December 17th
19 Apr, 2021 FinancialContent

Investors in NantHealth Inc (NH) saw new options begin trading this week, for the December 17th expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 242 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration..

Last Week's Notable Insider Buys Included Evergy, StoneMor, Tattooed Chef And More
18 Apr, 2021 FinancialContent

Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs. Even with a ...

Top Buys by Directors: Soon-shiong's $5M Bet on NH
16 Apr, 2021 FinancialContent

The directors of a company tend to have a unique inside view into the business, so when directors make major buys, investors are wise to take notice. Presumably the only reason a director of a company would choose to take their hard-earned cash and use it to buy stock in the open market, is that they expect to make money — maybe they find the stock very undervalued, or maybe they see exciting progress within the company, or maybe both..

Top Buys by Top Brass: Chief Executive Officer Soon-shiong's $5M Bet on NH
16 Apr, 2021 FinancialContent

A company's own top management tend to have the best inside view into the business, so when company officers make major buys, investors are wise to take notice. Presumably the only reason an insider would take their hard-earned cash and use it to buy stock of their company in the open market, is that they expect to make money — maybe they find the stock very undervalued, or maybe they see exciting progress within the company, or maybe both..

The Daily Biotech Pulse: Precision Biosciences Regains Rights To CAR T Candidates, CFO Changes, 2 IPOs
16 Apr, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

NantHealth Announces $137.5 Million New Financing With Highbridge Capital Management and Nant Capital
14 Apr, 2021 FinancialContent

NantHealth, Inc. (NASDAQ-GS: NH), a provider of enterprise solutions that help transform complex data into actionable insights, today announced the signing of a new financing that will include the issuance of $137.5 million aggregate principal amount of new senior unsecured convertible notes due 2026 (the "2026 Notes") in a private transaction, with the common stock that may be issued upon a conversion to be registered under the Securities Act of 1933, as amended (the "Securities Act"). As part of the transaction, the company will enter into an agreement to extend the maturity of its existing subordinated note to October 2026. The company intends to use the proceeds of the 2026 Notes to retire its existing convertible notes due December 2021 (the “2021 Notes”) and further invest in initiatives to grow its business.

NantHealth Unveils Population Health Management Tools to Help Payers and Providers Deliver on Value-Based Care Initiatives
31 Mar, 2021 FinancialContent

NantHealth, Inc. (NASDAQ: NH), today announced a new population health management product that pulls together disparate data to provide a full 360-degree picture of the patient while enabling better workflow between providers, payers, hospitals/healthcare networks and patients in one platform. This new product reduces avoidable costs and increases patient and provider satisfaction.

NantHealth Unveils Population Health Management Tools to Help Payers and Providers Deliver on Value-Based Care Initiatives
31 Mar, 2021 Yahoo! Finance

NantHealth, Inc. (NASDAQ: NH), today announced a new population health management product that pulls together disparate data to provide a full 360-degree picture of the patient while enabling better workflow between providers, payers, hospitals/healthcare networks and patients in one platform. This new product reduces avoidable costs and increases patient and provider satisfaction.

'Unless we vaccinate the entire planet, we won't get rid of this pandemic:' Vaccine developer
26 Mar, 2021 Yahoo! Finance

Controversial billionaire scientist Dr. Patrick Soon-Shiong discusses COVID-19 vaccine efforts.

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
23 Mar, 2021 FinancialContent

Gainers Plus Therapeutics (NASDAQ:PSTV) stock increased by 41.6% to $3.88 during Tuesday's pre-market session. The ...

NantHealth, Inc (NH) is a NASDAQ Common Stock listed in , ,

970x250